Previous Article | Next Article ![]()
Infection and Immunity, August 2001, p. 5198-5202, Vol. 69, No. 8
Department of Molecular Biology and
Biotechnology, University of Sheffield, Western Bank, Sheffield S10
2TN, United Kingdom
Received 29 January 2001/Returned for modification 16 March
2001/Accepted 25 April 2001
A model system mimicking Staphylococcus aureus
bacteremia was developed by growth in serum under microaerobic
conditions. Eight genes induced by growth in serum were identified,
including an antimicrobial peptide biosynthesis locus, amino acid
biosynthetic loci, and genes encoding putative surface proteins.
Nine independent insertions were found in the major lysine biosynthesis
operon, which encodes eight genes, is repressed by lysine in vitro, and is expressed in vivo.
Staphylococcus aureus is
a highly adaptable human pathogen in which differential gene expression
is known to occur in response to environmental conditions, both in
vitro (1, 8, 17) and in vivo (9). Previous
reports have demonstrated that in vitro conditions can be used to mimic
those in vivo, for example, the use of cell culture extracts and
mammalian cell cultures (13, 17). In this study, a model
system of growth in serum has been established and characterized.
Growth of S. aureus in serum.
S.
aureus 8325-4 (12) was grown in both brain heart
infusion (BHI) broth and pig serum (Sigma) under aerobic and
microaerobic conditions (8% O2-5%
CO2-87% N2). Microaerobic
growth in serum resulted in a higher growth rate and yield than did
aerobic growth (optical densities at 600 nm
[OD600], 6.1 and 4.2, respectively; 7 h)
(results not shown). Growth in human serum produced trends identical to
those seen in pig serum (results not shown). BHI gave a higher growth
yield than did serum and, in contrast to the results for serum, in BHI
aerobic growth was found to be optimal (OD600,
7.9 [microaerobic] and 10.2 [aerobic]; 7 h) (results not shown).
Identification of serum-expressed genes (seg).
Genes specifically induced in serum versus BHI were identified by
replica plating Tn917 insertion libraries (19)
on serum agar and BHI agar, both containing
5-bromo-4-chloro-3-indolyl- Identification of seg loci.
Following marker
rescue cloning and DNA sequencing (19), transposon
insertion sites were identified. In total, nine different seg genes were identified (Table
1). The genes insertionally inactivated
in mutants seg5, seg7, and
seg37 are all likely to encode surface proteins.
Thus, differentially expressed surface proteins that are produced by
S. aureus in serum may have a role in virulence.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.8.5198-5202.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Identification and Analysis of Staphylococcus
aureus Components Expressed by a Model System of Growth
in Serum
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
-D-galactopyranoside (X-Gal) (80 µg/ml). Following incubation at 37°C (microaerobic for
serum and aerobic for BHI), colonies that were blue on serum and
white on BHI were selected and rescreened. Twenty-three clones with
increased LacZ activity on serum were selected and further characterized. No growth defects on serum or BHI were observed for any
of the clones.
TABLE 1.
Characterization of serum-expressed genes
(seg)
-synthase; yjcI) biosynthesis (Table 1).
Lysine is a particularly important amino acid in S. aureus,
being required not only as a building block for proteins but also as a
component of the cell wall peptidoglycan. Interestingly, genes encoding
lysine biosynthetic enzymes (lysC, asd, dapA, dapB, and
lysA) have been identified not only in other in vitro
screens (8, 17) but also as mutations (asd,
ykuQ, and lysA) resulting in attenuation in vivo
(3, 10).
Analysis of lysC, asd, and dapA genes
in S. aureus.
Nine independent transposon
insertions were identified in genes involved in the biosynthesis of
lysine and the other aspartate family amino acids. The entire
dap locus was sequenced from S. aureus strain
8325-4, leading to the identification of a putative eight-gene
transcription unit termed the dap operon (Fig.
1). Protein homology suggests that the
dap operon contains six genes involved in the biosynthesis
of lysine. The dapB, ykuQ, and lysA genes encode
dihydrodipicolinate reductase, tetrahydrodipicolinate succinylase, and
diaminopimelate decarboxylase, respectively. Notably, the
dap genes are in the same order as they appear in the
biosynthetic pathway (Fig. 1) (17).
|
Amino acid requirements of selected seg mutants. A chemically defined medium (19) was adapted to allow the analysis of potential aspartate family amino acid auxotrophy (results not shown). These studies revealed that a mutation in lysC, asd, or dapA leads to lysine auxotrophy. Interestingly, while a mutation within the common pathway enzyme gene asd leads to an additional requirement for methionine and threonine, a lysC mutation does not. The phenotype of the lysC mutant can be explained only by the presence of multiple aspartokinase isozymes (as in B. subtilis) able to rescue the methionine and threonine biosynthesis functions of the lysC-encoded isozyme, but not lysine biosynthesis. The presence in S. aureus of a likely second aspartokinase isozyme homologous to aspartokinase III (yclM) of B. subtilis (44% over 171 amino acids) was confirmed by BLAST analysis of S. aureus databases (results not shown). Additionally, due to the genetic organization of the dap operon, where a lysC mutation is polar on asd, it is likely that a further promoter upstream of asd drives transcription independently of lysC.
Analysis of the expression and regulation of lysC, asd, and dapA. Reporter gene fusions MDW41 (lysC::lacZ), MDW42 (asd::lacZ), and MDW43 (dapA::lacZ), containing the fragments shown in Fig. 1, were cloned as BamHI-EcoRI PCR fragments into similarly digested pAZ106 (6). Recombinant plasmids were introduced into S. aureus RN4220 by electroporation (14), and the resulting chromosomal fusions were then transduced into S. aureus 8325-4 by phage transduction (12) and verified by Southern blot analysis (results not shown). The fusion strains all contained an intact copy of the dap operon. LacZ activity was measured as previously described (5).
Using the defined medium (19), the effects of Lys, Met, Thr, and Ile on the expression of the lacZ fusions were tested. Without any aspartate family amino acids, all fusion strains show a decreased growth rate but similar final yields compared to the results obtained with medium containing all four amino acids (Fig. 2a and b). All three fusions showed similar expression kinetics, being maximally expressed during the exponential phase and repressed >5-fold by Lys (Fig. 2). The addition of Met, Thr, and Ile had no effect in the absence of Lys (Fig. 2a and d), although the presence of all four aspartate family amino acids led to an almost complete lack of expression of any of the three fusions (Fig. 2b). These results suggest that serum lacks sufficient available Lys, leading to induction of the synthesis of the dap operon.
|
In vivo analysis of lysC, asd, and dapA. Using reverse transcription PCR and a murine pyelonephritis model (11), lysC, asd, and dapA were all shown to be expressed in vivo (results not shown). Three murine infection models (mouse abscess [2], pyelonephritis, and wound infection [11]) were used to investigate the role of lysC, asd, and dapA in vivo. In all three models, there was no significant difference between the number of cells recovered from the host following a 7-day infection for any of the mutant strains and the number recovered for the wild-type strain (results not shown). However, Lys biosynthetic components, including asd, have been shown to have roles in pathogenesis, as they have been identified during signature-tagged mutagenesis screening of S. aureus using bacteremia models of infection (3, 10).
The serum model is useful for the identification of genes which may contribute to the establishment (surface protein genes) and the persistence (biosynthetic genes) of S. aureus in the bloodstream. The serum screen is a simple and complementary approach to both signature-tagged mutagenesis and in vivo expression technology (3, 9, 10) and may allow environmental parameters important in the host to be elucidated. Further study of the role and regulation of the genes identified by these techniques will shed light on the complex processes involved in the ability of S. aureus to cause disease.Nucleotide sequence accession number. The sequence determined for the entire dap locus from S. aureus strain 8325-4 has been deposited in GenBank under accession number AF306669.
| |
ACKNOWLEDGMENTS |
|---|
We thank Martin Burnham (Glaxo SmithKline) and E. Ingham (University of Leeds, Leeds, United Kingdom) for help with in vivo models and useful discussions.
We are grateful to the Staphylococcus aureus Genome Sequencing project and to B. A. Roe, Y. Qian, A. Dorman, F. Z. Najar, S. Clifton, and J. Iandolo, who received funding from NIH and the Merck Genome Research Institute for preliminary sequence data. Sequence data were also obtained from The Institute for Genomic Research website (http://www.tigr.org) with support from NIH and the Merck Genome Research Institute. This research program was supported by the BBSRC (to M.D.W), the Royal Society (to S.J.F.), and Glaxo SmithKline.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Molecular Biology and Biotechnology, University of Sheffield, Firth Court, Western Bank, Sheffield S10 2TN, United Kingdom. Phone: 44 114 2224411. Phone: 44 114 2728697. E-mail: S.Foster{at}sheffield.ac.uk.
Editor: J. T. Barbieri
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Chan, P. F., and S. J. Foster. 1998. The role of environmental factors in the regulation of virulence-determinant expression in Staphylococcus aureus 8325-4. Microbiology 144:2469-2479[Abstract]. |
| 2. |
Chan, P. F.,
S. J. Foster,
E. Ingham, and M. O. Clements.
1998.
The Staphylococcus aureus alternative sigma factor B controls the environmental stress response but not starvation survival or pathogenicity in a mouse abscess model.
J. Bacteriol.
180:6082-6089 |
| 3. | Coulter, S. N., W. R. Schwan, E. Y. W. Ng, M. H. Langhorne, H. D. Ritchie, S. Westbrock-Wadman, W. O. Hufnagle, K. R. Folger, A. S. Bayer, and C. K. Stover. 1998. Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments. Mol. Microbiol. 30:393-404[CrossRef][Medline]. |
| 4. |
Hani, E. K., and V. L. Chan.
1995.
Expression and characterization of Campylobacter jejuni benzoylglycine amidohydrolase (hippuricase) gene in Escherichia coli.
J. Bacteriol.
177:2396-2402 |
| 5. |
Horsburgh, M. J.,
E. Ingham, and S. J. Foster.
2001.
In Staphylococcus aureus, Fur is an interactive regulator with PerR and is necessary for oxidative stress resistance through positive regulation of catalase, iron homeostasis, and virulence.
J. Bacteriol.
183:468-475 |
| 6. |
Kemp, E. H.,
R. L. Sammons,
A. Moir,
D. Sun, and P. Setlow.
1991.
Analysis of transcriptional control of the gerD spore germination gene of Bacillus subtilis 168.
J. Bacteriol.
173:4646-4652 |
| 7. | Kullik, I., R. Jenni, and B. Berger-Bachi. 1998. Sequence of the putative alanine racemase operon in Staphylococcus aureus: insertional interruption of this operon reduces D-alanine substitution of lipoteichoic acids and autolysis. Gene 219:9-17[CrossRef][Medline]. |
| 8. |
Lammers, A.,
E. Kruijt,
C. van de Kuijt,
P. J. M. Nuijten, and H. E. Smith.
2000.
Identification of Staphylococcus aureus genes expressed during growth in milk: a useful model for selection of genes important in bovine mastitis?
Microbiology
146:981-987 |
| 9. | Lowe, A. M., D. T. Beattie, and R. L. Deresiewicz. 1998. Identification of novel staphylococcal virulence genes by in vivo expression technology. Mol. Microbiol. 27:967-976[CrossRef][Medline]. |
| 10. | Mei, J., F. Nourbakhsh, C. W. Ford, and D. W. Holden. 1997. Identification of Staphylococcus aureus virulence genes in a murine model of bacteremia using signature-tagged mutagenesis. Mol. Microbiol. 26:399-407[CrossRef][Medline]. |
| 11. |
Nicholas, R. O.,
T. Li,
D. McDevitt,
A. Marra,
S. Sucoloski,
P. L. Demarsh, and D. R. Gentry.
1999.
Isolation and characterization of a sigB deletion mutant of Staphylococcus aureus.
Infect. Immun.
67:3667-3669 |
| 12. | Novick, R. P. 1991. Genetic systems in staphylococci. Methods Enzymol. 204:587-636[Medline]. |
| 13. | Renzoni, A., P. Cossart, and S. Dramsi. 1999. PrfA, the transcriptional activator of virulence genes, is up regulated during interaction of Listeria monocytogenes with mammalian cells and in eukaryotic cell extracts. Mol. Microbiol. 34:552-561[CrossRef][Medline]. |
| 14. | Schenk, S., and R. A. Laddaga. 1992. Improved methods for electroporation of Staphylococcus aureus. FEMS Microbiol. Lett. 94:133-138[CrossRef]. |
| 15. | Schnell, N., K.-D. Entian, U. Schneider, F. Gotz, H. Zahner, R. Kellner, and G. Jung. 1988. Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with 4 sulfide-rings. Nature 333:276-278[CrossRef][Medline]. |
| 16. | Schreier, H. J. 1993. Biosynthesis of glutamine and glutamate and the assimilation of ammonia, p. 281-298. In A. L. Sonenshein, J. A. Hoch, and R. Losick (ed.), Bacillus subtilis and other gram-positive bacteria: biochemistry, physiology, and molecular genetics. American Society for Microbiology, Washington, D.C. |
| 17. |
Vriesema, A. J. M.,
H. Beekhuizen,
M. Hamdi,
A. Soufan,
A. Lammers,
B. Willekens,
O. Bakker,
A. G. A. Welten,
M. H. A. M. Veltrop,
J. S. van de Gevel,
J. Dankert, and S. A. J. Zaat.
2000.
Altered gene expression in Staphylococcus aureus upon interaction with human endothelial cells.
Infect. Immun.
68:1765-1772 |
| 18. | Wasserman, S. A., E. Daub, P. Grisafi, D. Botstein, and C. T. Walsh. 1984. Catabolic alanine racemase from Salmonella typhimurium: DNA sequence, enzyme purification, and characterization. Biochemistry 23:5182-5187[CrossRef][Medline]. |
| 19. | Watson, S. P., M. Antonio, and S. J. Foster. 1998. Isolation and characterisation of Staphylococcus aureus starvation-induced, stationary-phase mutants defective in survival or recovery. Microbiology 144:3159-3169[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|